These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 31168879

  • 1. Donor-specific antibodies in a pediatric kidney transplant population-Prevalence and association with antiproliferative drug dosing.
    Strommen AM, Moss MC, Goebel J, Bock M.
    Pediatr Transplant; 2019 Sep; 23(6):e13511. PubMed ID: 31168879
    [Abstract] [Full Text] [Related]

  • 2. Impact of active antibody-mediated rejection treatment on donor-specific antibodies in pediatric kidney transplant recipients.
    Kincaide E, Hitchman K, Hall R, Yamaguchi I, Ding Y, Crowther B.
    Pediatr Transplant; 2019 Dec; 23(8):e13590. PubMed ID: 31617318
    [Abstract] [Full Text] [Related]

  • 3. Minimum mycophenolic acid levels are associated with donor-specific antibody formation.
    Filler G, Todorova EK, Bax K, Alvarez-Elías AC, Huang SH, Kobrzynski MC.
    Pediatr Transplant; 2016 Feb; 20(1):34-8. PubMed ID: 26589470
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):730-737. PubMed ID: 28339671
    [Abstract] [Full Text] [Related]

  • 6. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
    Lee H, Han E, Choi AR, Ban TH, Chung BH, Yang CW, Choi YJ, Oh EJ.
    PLoS One; 2018 Apr 01; 13(11):e0207434. PubMed ID: 30427941
    [Abstract] [Full Text] [Related]

  • 7. Human leukocyte antigen compatibility and incidence of donor-specific antibodies in pediatric liver transplant recipients.
    Melere MU, Feier FH, Neumann J, Kalil AN, Montagner JM, Nader LS, da Silva CS, Junior MAF, Coral GP, Bobsin GP, Ferreira CT.
    World J Gastroenterol; 2024 Sep 07; 30(33):3837-3845. PubMed ID: 39351427
    [Abstract] [Full Text] [Related]

  • 8. Pediatric kidney recipients may benefit from monitoring for donor-specific antibodies.
    Athavale D, Worthington J, Webb NJ, Roberts D, Martin S, Shenoy M.
    Pediatr Transplant; 2014 May 07; 18(3):258-65. PubMed ID: 24646402
    [Abstract] [Full Text] [Related]

  • 9. Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation.
    Caillard S, Becmeur C, Gautier-Vargas G, Olagne J, Muller C, Cognard N, Perrin P, Braun L, Heibel F, Lefebre F, Renner V, Gachet C, Moulin B, Parissiadis A.
    Transpl Int; 2017 Jan 07; 30(1):29-40. PubMed ID: 27678382
    [Abstract] [Full Text] [Related]

  • 10. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 07; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 11. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
    Fidler SJ, Irish AB, Lim W, Ferrari P, Witt CS, Christiansen FT.
    Transpl Immunol; 2013 Jun 07; 28(4):148-53. PubMed ID: 23665534
    [Abstract] [Full Text] [Related]

  • 12. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
    Tran A, Fixler D, Huang R, Meza T, Lacelle C, Das BB.
    J Heart Lung Transplant; 2016 Jan 07; 35(1):87-91. PubMed ID: 26422083
    [Abstract] [Full Text] [Related]

  • 13. Results of early treatment for de novo donor-specific antibodies in pediatric kidney transplant recipients in a cross-sectional and longitudinal cohort.
    Charnaya O, Tuchman S, Moudgil A.
    Pediatr Transplant; 2018 Mar 07; 22(2):. PubMed ID: 29356221
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS, Iniotaki AG, Kontou EN, Darema MN, Apostolaki MD, Kostakis AG, Boletis JN.
    Transpl Int; 2011 Nov 07; 24(11):1084-93. PubMed ID: 21848902
    [Abstract] [Full Text] [Related]

  • 15. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E, Eskandary F, Kozakowski N, Bond G, Kikić Ž, Yoo D, Rasoul-Rockenschaub S, Oberbauer R, Böhmig GA.
    Nephrol Dial Transplant; 2016 Aug 07; 31(8):1342-51. PubMed ID: 27190362
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D, Lee J, Schwartz JE, Friedlander R, Aull M, Muthukumar T, Campbell S, Epstein D, Seshan SV, Kapur S, Sharma VK, Suthanthiran M, Dadhania D.
    Transplantation; 2015 Jun 07; 99(6):1156-64. PubMed ID: 25629531
    [Abstract] [Full Text] [Related]

  • 17. C3d-binding Donor-specific HLA Antibody Is Associated With a High Risk of Antibody-mediated Rejection and Graft Loss in Stable Kidney Transplant Recipients: A Single-center Cohort Study.
    Lee DR, Kim BC, Kim JP, Kim IG, Jeon MY.
    Transplant Proc; 2018 Dec 07; 50(10):3452-3459. PubMed ID: 30503524
    [Abstract] [Full Text] [Related]

  • 18. Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients.
    Fichtner A, Süsal C, Schröder C, Höcker B, Rieger S, Waldherr R, Westhoff JH, Sander A, Dragun D, Tönshoff B.
    Nephrol Dial Transplant; 2018 Jun 01; 33(6):1065-1072. PubMed ID: 29444269
    [Abstract] [Full Text] [Related]

  • 19. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study.
    Castro A, Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    HLA; 2017 Nov 01; 90(5):267-275. PubMed ID: 28776960
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the current post-transplantation Human Leukocyte Antigen antibody screening in pediatric renal transplant recipients.
    Demirok A, Ranzijn C, Lardy J, Florquin S, Bouts A.
    Pediatr Transplant; 2019 Mar 01; 23(2):e13338. PubMed ID: 30635959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.